A new antibiotic that is supposed to be a lifesaver for people with superbugs is showing up in hospitals and on the market.
It’s the first drug approved by the U.S. Food and Drug Administration for the treatment of colitis.
The drug, called Pramipex, is made from the same antibiotic that killed off the deadly bacteria that caused the pandemic.
The drugs are not meant to treat everyone with colitis, but are designed to be safe for patients with a low risk of relapsing or recurrence.
Pramipexx is made by the Genentech-owned Sanofi company and will be sold to health care facilities and health insurers through Medicare, the government health insurance program for the elderly and disabled.
It’s expected to be available in the next two years.
The new drug is not a new type.
Earlier this year, the FDA approved another antibiotic called cephalosporin, but that drug is a brand name and does not treat people with chronic illnesses.
Prairie-dew mountain goats were found dead in the Wyoming desert in July and September and the Centers for Disease Control and Prevention said the cause of death could not be determined.
The Associated Press contributed to this report.